We have analyzed matched serum and breast cyst fluid samples for total PSA from 148 patients with fibrocystic breast disease. We have also determined the molecular forms of PSA (free PSA and PSA bound to alpha1-antichymotrypsin) in 78 breast cyst fluid samples. We found that total PSA can be detected in all cyst fluids and in about 75% of female sera. The median total PSA concentration in breast cyst fluid (bcf) is about 30 times higher than the median in the corresponding sera. Breast cyst fluid and serum PSA are not correlated with each other. Total serum PSA is inversely associated with patient age but the inverse association between bcf PSA and age is weak. Lower total PSA in bcf was seen in women who breast feed, and higher bcf PSA is associated with multiple cysts. Type I cysts (with a high K+/ Na+ ratio) tend to have higher total PSA than Type II cysts. All but three of the fractionated cyst fluids (75/78; 96%) had free PSA as the predominant molecular form. The most consistent finding of our study was the positive association between the cyst fluid K+/Na+ ratio and the free to bound PSA ratio. This association was confirmed by Spearman correlation as well as by Wilcoxon and chi-square analysis. Secretory/apocrine cysts (Type I) tend to have more total PSA and proportionally more free PSA than transudative/flattened cysts (Type II).
The purpose of this retrospective study was to analyze whether chemically sterilized tendon allografts perform as well as other non-sterilized allografts and autografts as described in the literature for anatomical acromioclavicular joint stabilization for the treatment of Rockwood III-V. Allografts are still described as a factor for higher re-rupture rates.Retrospective data were collected from 21 acromioclavicular joint stabilizations performed by a single surgeon and performed between 2011 and 2014 using sterilized semitendinosus allografts. The primary endpoints were re-rupture and complication rates. Secondary endpoints were AC-joint stability, pain level, return to work and sport and the range of motion.No re-ruptures occurred during the mean follow-up time of 33 months. Zero complications occurred directly after surgery, but three complications later than three weeks after surgery. All cases resolved without further surgery. After surgery, stability significantly improved for all patients. Post-surgery, 19 patients had stable acromioclavicular joints and only two patients showed minor instabilities. Range of motion returned to the range of the healthy shoulders for all patients.Chemically sterilized semitendinosus allograft use for anatomic AC-joint stabilization is equivalent to the use of other allografts or autografts and required no hardware removal. No donor age or graft size dependence was observed, due to zero re-ruptures.
It has been reported that tumor necrosis factor (TNF‐α) can precondition the heart against acute ischemia/reperfusion injury. This study examined if TNF‐α also plays a role in a long‐lasting cardioprotection induced by chronic hypoxia. Adult male Wistar rats were exposed for 30 days to chronic continuous hypoxia (CCH; inspired O 2 fraction 0.1); half of the animals were treated with a TNF‐α inhibitor infliximab (5 mg/kg i.p. once a week). Controls were kept at room air and treated in a corresponding manner. CCH increased the concentration of TNF‐α in particulate fraction of the left ventricle while the concentration of interleukin 10 (IL‐10) and the ratio of IL‐10 to TNF‐α decreased in both cytosolic and particulate fractions. Myocardial infarct size induced by 20‐min coronary artery occlusion and 3‐h reperfusion was reduced in CCH rats by 33% as compared with normoxic controls. This protective effect was attenuated in animals treated with infliximab, which had no effect in normoxic controls. The results suggest that adaptation to CCH results in the myocardial inflammatory response and TNF‐α is involved in the cardioprotective mechanism. Supported by grants GAAV IAAX01110901, GACR 303/12/1162.
No interactions related to the analytical method were observed between chlorpromazine (1) or carbamazepine (2) and activities of alanine aminotransferase (ALAT), aspartate aminotransferase (ASAT), glutamate dehydrogenase (GLDH) or lactate dehydrogenase (LDH). With respect to its cytotoxic potential 1 in cultures of isolated rat hepatocytes increased markedly the release of enzymes into the culture medium, whereas the overall activities of the enzymes were not influenced. 2 in cultured hepatocytes caused no significant effects on the activities of the enzymes investigated. Besides the investigation of methodically related interactions in pooled human serum the methodic procedure including the use of cultures of isolated hepatocytes allows to study also pharmacologically and toxicologically related interactions between drugs and diagnostically relevant liver enzymes.
